According to Xingqi Pharmaceutical's announcement, the company previously disclosed that it plans to repurchase shares for no less than 80 million yuan and no more than 100 million yuan. The repurchase price will not exceed 58 yuan/share to cancel and reduce registered capital. As of August 4, 2026, the company has repurchased a total of 2.405 million shares, accounting for 0.67% of the company's total share capital, with a total payment amount of 99.98 million yuan. The repurchase plan has been completed.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.